deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT03513731

Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint

Safety and Efficacy of Injection of Adipose-derived Regenerative Cells (ADRCs) in Patients Suffering From Osteoarthritis of the Facet Joints

Sponsor: InGeneron, Inc.

Conditions Osteoarthritis of Facet Joint of Lumbar Spine
Interventions Adipose-derived stem cell injection Corticosteroid injection
Updated 20 times since 2018 Last updated: Aug 15, 2025 Started: Dec 7, 2018 Primary completion: Dec 31, 2025 Completion: Apr 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03513731, this NA trial focuses on Osteoarthritis of Facet Joint of Lumbar Spine and remains actively recruiting participants. Sponsored by InGeneron, Inc., it has been updated 20 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Apr 2019 · 3 months · monthly snapshot~Apr 2019 – ~Aug 2019 · 4 months · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Aug 2020 · 5 months · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Jun 2022 · 17 months · monthly snapshot~Jun 2022 – ~Apr 2023 · 10 months · monthly snapshot~Apr 2023 – ~May 2024 · 13 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. May 2024 — Jul 2024 [monthly]

    Recruiting NA

  5. Apr 2023 — May 2024 [monthly]

    Recruiting NA

▶ Show 15 earlier versions

  1. Jun 2022 — Apr 2023 [monthly]

    Recruiting NA

  2. Jan 2021 — Jun 2022 [monthly]

    Recruiting NA

  3. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

  4. Aug 2020 — Sep 2020 [monthly]

    Recruiting NA

  5. Mar 2020 — Aug 2020 [monthly]

    Recruiting NA

  6. Feb 2020 — Mar 2020 [monthly]

    Recruiting NA

  7. Nov 2019 — Feb 2020 [monthly]

    Recruiting NA

  8. Aug 2019 — Nov 2019 [monthly]

    Recruiting NA

  9. Apr 2019 — Aug 2019 [monthly]

    Recruiting NA

  10. Jan 2019 — Apr 2019 [monthly]

    Recruiting NA

  11. Dec 2018 — Jan 2019 [monthly]

    Recruiting NA

  12. Oct 2018 — Dec 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  13. Sep 2018 — Oct 2018 [monthly]

    Not Yet Recruiting NA

  14. Jul 2018 — Sep 2018 [monthly]

    Not Yet Recruiting NA

  15. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • InGeneron, Inc.
  • Sanford Health
Data source: InGeneron, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations